E-Mart (139480)
Korea Stock Exchange · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 75,800.00 |
|---|---|
| 52-week range | 68,100.00 – 132,920.41 |
| Return, 1 month / 3 months | +1.1% / −5.6% |
| Return, 1 year / 3 years | +3.0% / +11.0% |
| Trend | Below its 200-day average |
| RSI (14) | 59 |
| Volatility (1 year) | 47.9% |
| Worst drawdown (1 year) | -44.3% |
| Average daily value traded | 8,396.24M KRW |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
E-Mart is a South Korean retailer that runs large discount stores selling groceries, household goods, clothing and electronics to everyday shoppers. Alongside its hypermarkets, it operates warehouse-style stores, smaller convenience formats and online shopping services. The company is based in Seoul and serves customers across Korea through its network of stores and delivery channels, offering food, home essentials and general merchandise under its own and other brands.
The shares are listed on the Korea Stock Exchange in Korea under the code 139480, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
E-Mart (139480) trades on the Korea Stock Exchange in Korea. It last closed at KRW 75,800.00 on 19 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 474 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.0% and over the last three months it fell 5.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.9% | ||
| From 52-week high | -39.0% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.6% | ||
| 6-month return | -19.7% | ||
| 12-month return, skipping the last month | 1.9% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 47.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.3% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 8,396.24M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +4.8% |
|---|---|
| 1 month | +1.1% |
| 3 months | −5.6% |
| 6 months | −19.7% |
| 1 year | +3.0% |
| 3 years | +11.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 74,370.00 / 87,003.32 |
|---|---|
| Golden / death cross (60 days) | Death, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2,403.64 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Mar 2026 | KRW 2,500.0000 |
| 1 Apr 2025 | KRW 2,000.0000 |
| 2 Apr 2024 | KRW 2,000.0000 |
| 28 Dec 2022 | KRW 2,000.0000 |
| 29 Dec 2021 | KRW 2,000.0000 |
| 29 Dec 2020 | KRW 2,000.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.